Black-market treatments — more precisely described as undisclosed or unregulated gemstone enhancements — are procedures applied to rough or cut stones outside the framework of recognised industry standards, without documentation, and typically without the knowledge of subsequent buyers in the supply chain. They range from crude dyeing with household colourants to sophisticated fracture-filling with unstable resins, and from undocumented irradiation to experimental heat treatments conducted in informal workshops far removed from any regulatory oversight. Unlike accepted trade enhancements, which are disclosed at point of sale and governed by the guidelines of bodies such as the American Gem Trade Association (AGTA), the Confédération Internationale de la Bijouterie, Joaillerie, Orfèvrerie (CIBJO), and the International Colored Gemstone Association (ICA), black-market treatments are deliberately or negligently concealed. Their consequences — for durability, for valuation, and for consumer trust — can be severe and long-lasting.

The Regulatory Landscape They Circumvent

The legitimate gemstone trade has developed detailed disclosure frameworks over several decades. AGTA's Gemstone Information Manual codifies a lettered treatment code system ("B" for bleaching, "F" for filling, "R" for irradiation, and so forth), requiring sellers to disclose any known enhancement at the time of sale. CIBJO's Gemstone Book similarly mandates disclosure of all treatments that are not permanent, that require special care, or that significantly affect value. The ICA's ethical guidelines echo these requirements. Accredited gemmological laboratories — including the Gemological Institute of America (GIA), Gübelin Gem Lab, Swiss Gemmological Institute (SSEF), and Lotus Gemology — issue reports that identify treatments where detectable, providing an independent verification layer.

Black-market treatments operate precisely in the gaps and blind spots of this system: in source-country cutting centres where documentation is rarely requested, in informal wholesale markets where verbal assurances substitute for paperwork, and in the hands of individual lapidaries or traders who apply enhancements speculatively before goods enter the formal trade. By the time a stone reaches a retail counter or auction estimate, the chain of custody has often obscured its history entirely.

Common Categories of Unregulated Enhancement

Several categories of treatment are particularly associated with undisclosed or non-standard practice:

• Fracture filling with unstable substances. While lead-glass filling of rubies became notorious after its widespread detection in the mid-2000s — and is now at least partially disclosed in many markets — the use of unstable organic resins, epoxies, or waxes in coloured stones remains common in informal trade. Unlike the borosilicate glass used in documented treatments, these substances may discolour under ultrasonic cleaning, dissolve in common jewellery chemicals, or collapse under heat. GIA and other laboratories have documented stones filled with materials that degrade within months of purchase.
• Non-standard dyeing. Organic dyes applied to porous stones — emeralds, turquoise, jadeite, lapis lazuli, and certain chalcedonies — are a longstanding informal practice. Reputable trade dyeing of, for example, black onyx (a stable and widely accepted treatment) is disclosed; the application of fugitive dyes to low-quality material to simulate higher grades is not. Infrared spectroscopy and chemical spot tests can often identify foreign organic compounds, but only if a laboratory examination is requested.
• Undocumented irradiation. Irradiation is a legitimate and accepted treatment for certain stones — blue topaz, some yellow and green diamonds, certain sapphires and tourmalines — when properly disclosed and, where regulations require it, certified as radiologically safe for handling. Undocumented irradiation, conducted without dosimetry records or safety certification, presents both a disclosure problem and, in extreme cases involving short-lived isotopes, a potential handling risk. Regulatory agencies in several countries require that irradiated gemstones meet specific residual radioactivity thresholds before commercial release; stones treated in unmonitored facilities may not meet these standards.
• Beryllium diffusion without disclosure. The discovery of beryllium diffusion treatment in corundum — first publicly documented in the early 2000s — demonstrated how a genuinely novel treatment can enter the market at scale before laboratories develop detection protocols. Stones treated in this manner were sold as untreated or as simply heat-treated for years. Though detection methods are now well established, the episode illustrated how rapidly an unregulated treatment can penetrate the supply chain.
• Polymer impregnation of jadeite and other porous materials. "Type B" jadeite — bleached and polymer-impregnated — has been a documented concern in the jade trade for decades. The treatment is detectable by Fourier-transform infrared spectroscopy (FTIR), but stones are routinely sold in informal markets without disclosure. Similar polymer treatments are applied to turquoise, coral, and certain opaque coloured stones.

Geographic and Supply-Chain Contexts

Unregulated treatments tend to concentrate at specific nodes in the global supply chain. Cutting and treatment centres in certain producing regions — historically including parts of Thailand, India, and China, though the problem is not exclusive to any geography — have operated with minimal external oversight, particularly for lower-value goods. The informal gem bazaars of Bangkok's Chanthaburi district, the wholesale markets of Jaipur, and the jade markets of Ruili have all at various times been associated with undisclosed treatment practices, alongside legitimate and highly professional operations. It would be inaccurate and unfair to characterise any single market as uniformly problematic; the issue is structural rather than national.

The problem is compounded by the length and opacity of the supply chain. A stone may pass through a miner, a local broker, a country exporter, an international wholesaler, and a retail jeweller before reaching a consumer, with each transaction potentially obscuring what the previous party knew. Disclosure obligations, where they exist legally, typically apply only at the final point of consumer sale — meaning that informal treatment and concealment earlier in the chain may be technically outside the reach of retail consumer-protection law.

Detection and Laboratory Identification

Accredited gemmological laboratories have developed increasingly sophisticated protocols for identifying non-standard treatments. Key analytical tools include:

• Fourier-transform infrared spectroscopy (FTIR), which identifies foreign organic substances in fractures and along grain boundaries.
• Energy-dispersive X-ray fluorescence (EDXRF) and laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS), used to detect anomalous trace elements consistent with diffusion treatments.
• Ultraviolet fluorescence examination, which can reveal uneven distribution of filling materials or dyes.
• Raman spectroscopy, used to characterise filling substances and surface coatings.
• Standard gemological microscopy, which remains indispensable for identifying flux residues, unusual inclusions, and the characteristic surface features of treated stones.

When a laboratory detects evidence of a non-standard or unidentifiable treatment, it will typically note this on the report with language such as "clarity enhanced by an unidentified substance" or "evidence of surface coating" — stopping short of characterising the treatment as fraudulent, but clearly flagging that the stone does not meet standard disclosure expectations. GIA's reports, for instance, will decline to grade a stone as "no indications of heating" if anomalous features suggest undisclosed thermal or diffusion treatment.

Market and Legal Consequences

The financial consequences of undisclosed treatment can be substantial. A ruby sold as unheated commands a significant premium over a heat-treated equivalent — often several multiples of the treated price at fine quality levels. A jadeite piece sold as "Type A" (untreated) is valued far above a polymer-impregnated "Type B" stone of similar appearance. When undisclosed treatments are discovered post-purchase, buyers have grounds for rescission of sale in most common-law and civil-law jurisdictions, on the basis of misrepresentation or non-disclosure of a material fact. Several high-profile cases have resulted in litigation or arbitration, and at least one major auction house has faced significant reputational scrutiny following the sale of stones later identified as bearing undisclosed treatments.

For the trade, the systemic risk is reputational. Consumer confidence in coloured gemstones — already lower than in diamonds, partly because treatment disclosure has historically been less rigorous — is further eroded each time a significant undisclosed treatment case becomes public. Industry bodies have responded with increasingly stringent disclosure requirements and educational programmes, but enforcement remains difficult in the absence of mandatory pre-sale laboratory certification, which no major market currently requires by law for coloured stones.

Buyer Guidance and Due Diligence

For purchasers of significant coloured gemstones, the practical implications are clear. A laboratory report from an accredited institution — GIA, Gübelin, SSEF, Lotus Gemology, or equivalent — is the most reliable available assurance that a stone has been examined for known treatments. For rubies, sapphires, and emeralds above modest value thresholds, such a report should be considered standard rather than optional. Buyers should be alert to stones offered without documentation at prices that seem inconsistent with the quality claimed, and should understand that verbal assurances of treatment status, however sincerely offered, are not a substitute for independent laboratory examination. The AGTA and ICA both maintain resources on treatment disclosure that provide useful orientation for non-specialist buyers.

Further Reading

• GIA: Gem Treatments Overview
• AGTA Gemstone Information Manual
• ICA: Treatments and Enhancements
• Lotus Gemology: Laboratory Articles and Treatment Alerts